Cinctive Capital Management LP Buys 11,083 Shares of Danaher Corporation $DHR

Cinctive Capital Management LP increased its stake in shares of Danaher Corporation (NYSE:DHR) by 90.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,298 shares of the conglomerate’s stock after acquiring an additional 11,083 shares during the quarter. Cinctive Capital Management LP’s holdings in Danaher were worth $5,333,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. JPL Wealth Management LLC acquired a new position in Danaher during the third quarter worth $25,000. WFA of San Diego LLC acquired a new position in Danaher during the second quarter worth $26,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the third quarter worth $27,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth $27,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Barclays dropped their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. The Goldman Sachs Group dropped their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Guggenheim dropped their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Finally, Jefferies Financial Group reissued a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $233.61.

Danaher Trading Down 1.9%

Shares of Danaher stock opened at $177.85 on Thursday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm has a market cap of $125.88 billion, a PE ratio of 34.40, a PEG ratio of 2.31 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a 50 day simple moving average of $180.26 and a two-hundred day simple moving average of $203.59.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the business posted $1.88 earnings per share. Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. Analysts expect that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.